Skip to main content
. 2018 Nov 2;41(1):113–124. doi: 10.3892/or.2018.6851

Figure 1.

Figure 1.

Schedule of the present study. The order of analyses conducted to develop the risk score model and validate the efficiency of the signature to predict outcomes. CircRNA, circular RNA; ROC, receiver operating characteristic; AUC, area under curve.